Stock price movements
On October 16, UnitedHealth Group (UNH) closed at $272.57, which was 4.73% higher than its previous closing price. This was a reaction to the stronger-than-anticipated third-quarter earnings reported by the company that date.
UnitedHealth Group reported revenues of $56.56 billion and adjusted EPS of $3.41 in the third quarter, representing YoY (year-over-year) increases of 12.4% and 28.0%, respectively. In the third quarter, the company surpassed consensus estimates for both revenues and adjusted EPS by $160.0 million and $0.12, respectively.
On October 17, UnitedHealth Group closed at $267.30, which was 1.93% lower than its previous closing price. The stock has declined by 0.69% from $269.10 on October 1 to $267.30 on October 17.
Based on its closing price on October 17, the company has returned 1.6% in the last week, 1.52% in the last month, and 5.68% in the last quarter. UnitedHealth Group returned 13.38% in the last half year, 31.1% in the last year, and 21.25% YTD.
Analysts’ recommendations and target price
The 12-month consensus analyst recommendation for UnitedHealth Group on October 17 was for a “buy.” The 12-month consensus target price for the company is $305.57, which is 14.32% higher than its last closing price on October 17. The highest target price estimate for the company is $330.00, and the lowest target price estimate is $269.00.
Out of the 24 analysts covering UnitedHealth Group on October 17, the majority of analysts have given favorable ratings for the stock. Ten analysts rated the company as a “strong buy,” and 13 analysts rated the company as a “buy.” One analyst rated the company as a “hold.”
In the next article, we’ll discuss the revenue and earnings estimates for UnitedHealth Group for fiscal 2018.